Recent Close Relations with Canada. The company has agreed with the country’s government to start producing mRNA vaccines, by creating Vaccine factory in QuebecAccording to the company, in a statement. The agreement is valid for ten years.
Once operational, the facility is expected to provide access to a range of Canadian-made mRNA vaccines against various respiratory viruses, Including Covid-19, seasonal influenza, respiratory syncytial virus (RSV), and other possible respiratory viruses.
In the event of a future pandemic, the facility is expected to be activated on an urgent basis to support Canada in direct access to rapid response capabilities, with the ability to adapt and adjust manufacturing. The intent is to tackle new or existing emerging viruses.
“The planned research and development (R&D) commitments will contribute to the growth of the life sciences ecosystem in Canada, providing significant support to the Canadian government’s biomanufacturing and life sciences strategy,” said Patricia Gauthier, President and CEO of Moderna Canada.
Moderna says its vaccine against Covid-19 is 93% effective.
mRNA vaccines do not contain actual viruses, but instead give instructions to human cells to make proteins that mimic part of the coronavirus. Last week, Moderna clarified that its Covid-19 vaccine has Effectiveness of about 93% over the six months following the second dose.
In Spain, Moderna consolidated its position in the first months of 2022. In fact, the American biotechnology company, which has an agreement in the country with Rovi Pharmaceutical Laboratories, It plans to end the year with the manufacture of 500 million doses of its Covid-19 vaccine. So far, the company has manufactured just over 350 million doses of the Covid-19 vaccine in Spain, which has distributed them to more than sixty countries.